Helferich and colleagues described an miR-1825/TBCB/TUBA4A pathway, demonstrating that the reduced expression of an upstream miRNA can lead to a reduction in TUBA4A protein expression in ALS patients [31]. The gene discussed is TBCB; the disease is amyotrophic lateral sclerosis.